WATCH Nippon Shinyaku Co., Ltd. (4516.T)
Healthcare · Drug Manufacturers - Specialty & Generic · JPX · Japan
56
Final Score
-17.4%
Margin of Safety
71
Quality Score
¥3,549
Current Price
¥239.2B
Market Cap
Key Metrics
Pe Ratio
8.05
Forward Pe
8.64
Pb Ratio
0.81
Ev Ebitda
4.03
Roe
11.5%
Gross Margin
65.3%
Operating Margin
25.1%
Net Margin
17.5%
Dividend Yield
350.0%
Debt To Equity
0.86
Current Ratio
4.66
📈 Trend Charts
Revenue Trend
EPS Trend
Net Income Trend
Free Cash Flow Trend
Intrinsic Value Estimates
Low
¥2,418
Base
¥3,022
High
¥3,627
Pipeline Stage Details
Stage A — Hard Filters ✅
Pe Ratio
8.05
Eps Positive Years
4.00
Eps Lookback
4.00
Fcf Positive Years
4.00
Fcf Lookback
4.00
Debt To Equity
0.86
Current Ratio
4.66
Dilution Cagr
0.00
Stage B — Quality Score: 71/100
Stage C — Cyclicality: LOW
Normalized EPS
¥411.69
Stage F — Final Score Breakdown
| Component | Weighted Score |
|---|---|
| Valuation | 3.0 |
| Earnings Quality | 17.7 |
| Balance Sheet | 15.0 |
| Stability | 12.0 |
| Moat Proxies | 7.9 |
Top Drivers
- High quality business (score 71/100): above-average returns on capital and reliable earnings generation.
- Low P/E of 8.0x — classic Graham deep-value territory. The market is pricing in pessimism, yet the business continues to generate positive earnings.
- Solid ROIC of 13.3% — above the 12% threshold, indicating the business creates genuine economic value for shareholders.
- Conservative leverage: D/E ratio of 0.86x is well within Graham's maximum of 1.0x, reducing insolvency risk.
- Strong free cash flow generation — the company converts earnings into real cash effectively, supporting dividends, buybacks, and debt reduction.
Top Risks
- No significant risks identified in this analysis.
Financial History
| Year | Revenue | Gross Profit | Operating Income | Net Income | EPS |
|---|---|---|---|---|---|
| 2023 | ¥144.2B | ¥88.2B | ¥30.1B | ¥22.8B | ¥338.70 |
| 2024 | ¥148.3B | ¥98.0B | ¥33.3B | ¥25.9B | ¥383.82 |
| 2025 | ¥160.2B | ¥109.1B | ¥35.5B | ¥32.6B | ¥483.26 |
| 2026 | ¥170.8B | ¥113.3B | ¥35.5B | ¥29.7B | ¥441.00 |
Cash Flow History
| Year | Operating CF | CapEx | Free Cash Flow |
|---|---|---|---|
| 2022 | N/A | N/A | N/A |
| 2023 | ¥26.2B | ¥-11.7B | ¥14.4B |
| 2024 | ¥16.3B | ¥-9.6B | ¥6.6B |
| 2025 | ¥36.1B | ¥-34.8B | ¥1.3B |
| 2026 | ¥27.2B | ¥-3.8B | ¥23.4B |